Could a simple change in pill timing give people with epilepsy more Seizure-Free days?
NCT ID NCT07490769
Summary
This study is testing if taking the epilepsy drug levetiracetam three times a day works better and is easier to tolerate than the standard twice-a-day schedule. It involves 120 adults whose seizures are not fully controlled on their current high-dose, twice-daily regimen. Each participant will try the new three-times-daily schedule and track their seizures and any side effects in a daily diary to see if it helps them have more days without seizures.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
King Saud University
RECRUITINGRiyadh, Riyadh Region, 13321, Saudi Arabia
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.